Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1928-1934
Published online before print August 26, 2004, doi: 10.1161/01.ATV.0000143385.30354.bb
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/10/1928    most recent
01.ATV.0000143385.30354.bbv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, X.
Right arrow Articles by Lusis, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, X.
Right arrow Articles by Lusis, A. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Gene expression
Right arrow Genetically altered mice
Right arrow Genetics of cardiovascular disease
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1928.)
© 2004 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Hyplip2, a New Gene for Combined Hyperlipidemia and Increased Atherosclerosis

Xuping Wang; Peter Gargalovic; Jack Wong; Jennifer L. Gu; Xiaohui Wu; Hongxiu Qi; Pingzi Wen; Li Xi; Bing Tan; Rocky Gogliotti; Lawrence W. Castellani; Aurobindo Chatterjee; Aldons J. Lusis

From the Departments of Medicine, Microbiology, Immunology, and Molecular Genetics, and Human Genetics (X.Wang, P.G., J.W., X.Wu, H.Q., P.W., L.W.C., A.J.L.), University of California, Los Angeles; the Division of Biology (J.L.G.), California Institute of Technology, Pasadena; and the Department of Cardiovascular Molecular Sciences and Technologies (L.X., B.T., R.G., A.C.), Pfizer Global Research & Development, Ann Arbor, Mich.

Correspondence to Aldons J. Lusis, Department of Medicine/Division of Cardiology, 47-123 CHS, UCLA, Los Angeles, CA 90095-1679. E-mail jlusis{at}mednet.ucla.edu

Objective— We previously reported the mapping of a quantitative trait locus (QTL) on chromosome 15 contributing to hyperlipidemia in a cross between inbred strains MRL/MpJ (MRL) and BALB/cJ (BALB). Using marker-assisted breeding, we constructed a congenic strain in which chromosome 15 interval from MRL is placed on the genetic background of BALB. The congenic allowed us to confirm the QTL result and to further characterize the properties and location of the underlying gene.

Methods and Results— On chow and high-fat (atherogenic) diets, the congenic mice exhibited higher levels of plasma triglycerides and cholesterol than BALB mice. In response to the atherogenic diet, the congenic mice but not BALB mice exhibited a dramatic {approx}30-fold increase in atherogenic lesions accompanied by {approx}2-fold decrease in high-density lipoprotein cholesterol levels. With respect to atherosclerotic lesions and some lipid parameters, this chromosome 15 gene, designated Hyplip2, exhibited dominant inheritance. Expression array analyses suggested that Hyplip2 may influence inflammatory and bile acid synthesis pathways. Finally, we demonstrated the usefulness of subcongenic strains to narrow the locus (50 Mbp) with the goal of positionally cloning Hyplip2.

Conclusions— Our data demonstrate that the Hyplip2 gene significantly contributes to combined hyperlipidemia and increased atherosclerosis in mice.

We have investigated the vasorelaxant properties of CRP using commercial preparations of CRP, CRP purified from ascites, and our in-house recombinant CRP. We conclude that CRP has no vasorelaxant properties, and previous studies reporting such responses are artifacts caused by sodium azide present in commercial preparations of CRP.


Key Words: hyperlipidemia • atherosclerosis • QTL • chromosome 15 • FCHL




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
C. Zhou, N. King, K. Y. Chen, and J. L. Breslow
Activation of PXR induces hypercholesterolemia in wild-type and accelerates atherosclerosis in apoE deficient mice
J. Lipid Res., October 1, 2009; 50(10): 2004 - 2013.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. J. A. Moen, A. P. Tholens, P. J. Voshol, W. de Haan, L. M. Havekes, P. Gargalovic, A. J. Lusis, K. W. van Dyk, R. R. Frants, M. H. Hofker, et al.
The Hyplip2 locus causes hypertriglyceridemia by decreased clearance of triglycerides
J. Lipid Res., October 1, 2007; 48(10): 2182 - 2192.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
O. Seda, L. Sedova, F. Liska, D. Krenova, V. Prejzek, L. Kazdova, J. Tremblay, P. Hamet, and V. Kren
Novel double-congenic strain reveals effects of spontaneously hypertensive rat chromosome 2 on specific lipoprotein subfractions and adiposity
Physiol Genomics, January 12, 2007; 27(1): 95 - 102.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Zhang, X. Wang, C. Vales, F. Y. Lee, H. Lee, A. J. Lusis, and P. A. Edwards
FXR Deficiency Causes Reduced Atherosclerosis in Ldlr-/- Mice
Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2316 - 2321.
[Abstract] [Full Text] [PDF]